
A recently published, peer-reviewed research article has concluded that the inhibition of mast cells with AB Science’s masitinib could represent …

AB Science has revealed that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a …
Pharma sees climate disruption as growing supply-chain risk
Manchester NHS-MHRA partnership to test new technologies in real-world care

